Form 4: iBio Director William D. Clark Acquires Stock Options

Director William D. Clark of iBio, Inc. acquired 18,900 stock options on November 21, 2024, which vest monthly over twelve months.

Summary

• William D. Clark, a director at iBio, Inc., acquired 18,900 stock options on November 21, 2024.
• These options have an exercise price of $2.45.
• The options vest pro rata on a monthly basis over twelve months, starting from the grant date.
• The options expire on November 20, 2034.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock option grant, which is neither particularly positive nor negative. It is a standard practice for director compensation.

Positives

• The acquisition of stock options by a director may indicate confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's securities. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies as part of their compensation packages.
• The vesting schedule of monthly over 12 months is also a typical arrangement.
• The 10-year expiration period is also standard for stock options.

Stakeholder Impact

• The stock option grant may have a minor positive impact on shareholder sentiment as it aligns director interests with the company's performance.

Key Dates

Keywords

stock options, insider trading, director, iBio, equity, compensation